Keating Financial Advisory Services, Inc.
Position in PCRX — Pacira BioSciences, Inc.
CIK 2103443
MANHATTAN, KS
Position in PCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$109,877
+$2,098 QoQ
Shares Held
4,331
-9.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#172
of 251 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Keating Financial Advisory Services, Inc. holds $902,372 across 26 Drug Manufacturers - Specialty & Generic names. PCRX ranks #3 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
3,639 | $403,710 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
3,062 | $144,740 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
This page
|
4,331 | $109,877 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
149 | $80,732 | |
| 5 | AQST |
Aquestive Therapeutics, Inc.
|
12,563 | $52,262 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
526 | $21,581 | |
| 7 | VTRS |
Viatris Inc
|
1,268 | $20,135 | |
| 8 | ZTS |
Zoetis Inc.
|
238 | $17,102 |
All Filings in PCRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $109,877 | 4,331 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $107,779 | 4,769 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,846,356 | 71,343 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||